Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CA7 | P43166 | 2/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 6/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | ANPEP | P15144 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7050916 | 0.82 | — | — | |
| SCHEMBL426048 | 0.77 | MEN1 (0.51) | KDM4ECA12CA7CA14CA2 | |
| SCHEMBL5518034 | 0.77 | — | — | |
| SCHEMBL28068382 | 0.77 | CA1 (0.43) | CA2CA1HRH3ANPEPUSP2 | |
| SCHEMBL778925 | 0.76 | CA12 (0.42) | KDM4ECA12CA7CA14SMN1; SMN2 | |
| SCHEMBL4021995 | 0.76 | KDM4E (0.45) | KDM4ECA12CA7CA14SMN1; SMN2 | |
| SCHEMBL2377137 | 0.76 | CA12 (0.42) | KDM4ECA12CA7CA14SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL1291175 | 0.76 | MEN1 (0.50) | KDM4ECA12CA7CA14CA2 | |
| Hydrochloric Acid SCHEMBL23249493 | 0.75 | CA1 (0.36) | CA2CA1HRH3 | |
| SCHEMBL18064889 | 0.75 | CA1 (0.48) | CA2CA1HRH3TSHRANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0707094-B1 | Process for preparing perfluoroalkanesulfonyl fluorides | MINNESOTA MINING & MFG (US) | 1998-07-22 | — | — | EP | claimed |
| EP-0707094-A1 | Process for preparing perfluoroalkanesulfonyl fluorides | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-04-17 | — | — | EP | claimed |
| US-12478680-B2 | Hydrogels with biodegradable crosslinking | PROLYNX LLC (US) | 2025-11-25 | — | — | US | disclosed |
| US-20230135347-A1 | HYDROGELS WITH BIODEGRADABLE CROSSLINKING | PROLYNX LLC (US) | 2023-05-04 | — | — | US | disclosed |
| US-11454861-B2 | Hydrogels with biodegradable crosslinking | PROLYNX LLC (US) | 2022-09-27 | — | — | US | disclosed |
| EP-3464253-A1 | AUTOTAXIN INHIBITORS | University of Tennessee Research Foundation (US) | 2019-04-10 | — | — | EP | disclosed |
| WO-2017210527-A1 | AUTOTAXIN INHIBITORS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2017-12-07 | — | — | WO | disclosed |
| US-7250444-B2 | Pyrrole-based HMG-CoA reductase inhibitors | PFIZER INC. (US) | 2007-07-31 | — | — | US | disclosed |
| US-20060287378-A1 | Novel pyrroles and imidazoles | WARNER-LAMBERT COMPANY LLC | 2006-12-21 | — | — | US | disclosed |
| EP-1656132-A2 | NOVEL PYRROLE-BASED HMG-COA REDUCTASE INHIBITORS | Warner-Lambert Company LLC (US) | 2006-05-17 | — | — | EP | disclosed |
| US-20050043364-A1 | Novel pyrrole-based HMG-CoA reductase inhibitors | KENNEDY ROBERT MICHAEL (US) | 2005-02-24 | — | — | US | disclosed |
| WO-2005014539-A2 | PYRROLE-BASED HMG-COA REDUCTASE INHIBITORS | WARNER-LAMBERT COMPANY LLC (US) | 2005-02-17 | — | — | WO | disclosed |
| EP-0707094-B1 | Process for preparing perfluoroalkanesulfonyl fluorides | MINNESOTA MINING & MFG (US) | 1998-07-22 | — | — | EP | disclosed |
| EP-0707094-A1 | Process for preparing perfluoroalkanesulfonyl fluorides | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-04-17 | — | — | EP | disclosed |
| US-5486271-A | Process for preparing perfluoroalkanesulfonyl fluorides | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-01-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050043364-A1 | Novel pyrrole-based HMG-CoA reductase inhibitors | HMGCR, DHCR7, HSD17B12 | KDM4E 1231/4885CA12 4620/4885CA7 4085/4885 |
| US-20230135347-A1 | HYDROGELS WITH BIODEGRADABLE CROSSLINKING | IDUA, APEH, GUSB | KDM4E 1047/4885CA12 914/4885CA7 323/4885 |
| US-20060287378-A1 | Novel pyrroles and imidazoles | PPIP5K2, PPIE, PPOX | KDM4E 813/4885CA12 4451/4885CA7 3295/4885 |
| US-11454861-B2 | Hydrogels with biodegradable crosslinking | IDUA, APEH, GUSB | KDM4E 1047/4885CA12 914/4885CA7 323/4885 |
| US-12478680-B2 | Hydrogels with biodegradable crosslinking | IDUA, APEH, GUSB | KDM4E 1047/4885CA12 914/4885CA7 323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.